Risankizumab treatment in psoriasis patients who failed anti‐IL17: A 52‐week real‐life study. - Megna, Matteo; Potestio, Luca; Ruggiero, Angelo; Camela, Elisa; Fabbrocini, Gabriella (Dermatologic Therapy, 2022)